RBM6-RBM5 Chimeras in Tumors
Author Information
Author(s): Wang Ke, Ubriaco Gino, Sutherland Leslie C
Primary Institution: Regional Cancer Program of the Sudbury Regional Hospital
Hypothesis
The study investigates the existence and expression of RBM6-RBM5 chimeric transcripts in tumor tissues.
Conclusion
RBM6-RBM5 chimeric transcripts are differentially expressed in tumor tissues and may serve as potential tumor differentiation markers.
Supporting Evidence
- Three novel chimeric transcripts were identified and characterized.
- Differential expression was observed in tumor versus non-tumor tissues.
- Chimeric expression was associated with increased tumor size in breast cancer.
Takeaway
Scientists found new RNA pieces made from two genes that change how they work in tumors, which might help doctors tell how serious the tumors are.
Methodology
Nested PCR was used to identify chimeric transcripts from RNA extracted from various tumor and non-tumor tissues.
Limitations
Insufficient pathological information was available for some tumor types to evaluate expression differences.
Participant Demographics
Breast tumor samples from patients aged 33 to 86 years.
Statistical Information
P-Value
p = 0.063
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website